Natural Product: NPC478515

Natural Product IDNPC478515
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
HCMPHRZWEQQNRE-UHFFFAOYSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 134146015
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones
          • [CHEMONTID:0003501] 3-prenylated flavones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HCMPHRZWEQQNRE-UHFFFAOYSA-N
Standard InCHI InChI=1S/C29H28O8/c1-15(2)7-9-21-26(33)25-22(32)14-24-20(11-12-29(5,6)37-24)28(25)36-27(21)19-10-8-18(34-16(3)30)13-23(19)35-17(4)31/h7-8,10-14,32H,9H2,1-6H3
SMILES CC(=CCc1c(=O)c2c(cc3c(C=CC(C)(C)O3)c2oc1c1ccc(cc1OC(=O)C)OC(=O)C)O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   504.18 Volume:   514.599
?
Van der Waals volume.
Dense:   0.98 LogP:   5.345
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.983
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.638
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   26.0
TPSA:   112.27
?
Topological Polar Surface Area.
H-Bond Acceptor:   8.0
H-Bond Donor:   1.0 Rings:   4.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.267 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.324 Fsp3:   0.276
MCE-18:   59.568
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.869 Fluc inhibitor:   0.471
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.939
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.833
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.202 Promiscuous compounds:   0.171

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.935 MDCK Permeability:   -4.578
Pgp-inhibitor:   0.986 Pgp-substrate:   0.1
PAMPA:   0.379
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.008
20% Bioavailability (F20%):   0.987 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.023 MRP1:   0.985
Plasma Protein Binding (PPB):   95.505% Volume Distribution (VD):   0.313
Fu: 3.915%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.999 BCRP inhibitor:   0.774
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.754 CYP2C19-substrate:   0.989
CYP2C9-inhibitor:   0.002 CYP2C9-substrate:   0.251
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.978
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   1.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.14 Half-life (T1/2):  0.769

ADMET: Toxicity

hERG Blockers:  0.012 hERG Blockers (10um):  0.253
Human Hepatotoxicity (H-HT):  0.404 Drug-induced Liver Injury (DILI):  0.973
AMES Toxicity:  0.549 Rat Oral Acute Toxicity:  0.838
Maximum Recommended Daily Dose:  0.352 Skin Sensitization:  0.967
Carcinogencity:  0.336 Eye Corrosion:  0.001
Eye Irritation:  0.247 Respiratory Toxicity:  0.792
Drug-induced Neurotoxicity:  0.163 Ototoxicity:  0.139
Hematotoxicity:  0.316 Drug-induced Nephrotoxicity:  0.119
Genotoxicity:  0.969 RPMI-8226 Immunitoxicity:  0.028
A549 Cytotoxicity:  0.356 Hek293 Cytotoxicity:  0.299
BCF:   1.662
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.751
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.614
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.174
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11796 Morus australis Species Moraceae Eukaryota n.a. root n.a. PMID[17405024]
NPO11796 Morus australis Species Moraceae Eukaryota Root Bark n.a. n.a. PMID[27908762]
NPO11796 Morus australis Species Moraceae Eukaryota n.a. n.a. n.a. PMID[9358644]
NPO11796 Morus australis Species Moraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11796 Morus australis Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11796 Morus australis Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11796 Morus australis Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell line RAW264.7 Mus musculus Inhibition = 58.7 % PMID[27908762]
NPT113 Cell line RAW264.7 Mus musculus Inhibition = 69.2 % PMID[27908762]
NPT113 Cell line RAW264.7 Mus musculus Inhibition = 40.4 % PMID[27908762]
NPT113 Cell line RAW264.7 Mus musculus IC50 = 2.4 ug.mL-1 PMID[27908762]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 93.27 % PMID[27908762]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 90.01 % PMID[27908762]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 90.22 % PMID[27908762]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 10150.0 nM PMID[27908762]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Activity = 91.0 % PMID[27908762]
NPT32 Organism Mus musculus Mus musculus Activity = 80.3 % PMID[27908762]
NPT32 Organism Mus musculus Mus musculus Activity = 36.6 % PMID[27908762]
NPT32 Organism Mus musculus Mus musculus Activity = 13.9 % PMID[27908762]
NPT32 Organism Mus musculus Mus musculus Activity = 11.7 % PMID[27908762]
NPT32 Organism Mus musculus Mus musculus Activity = 96.0 % PMID[27908762]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC478515 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6747 Remote Similarity NPC62840
0.6548 Remote Similarity NPC276444
0.6512 Remote Similarity NPC600012
0.5889 Remote Similarity NPC198829
0.5843 Remote Similarity NPC478514
0.5618 Remote Similarity NPC189087
0.5618 Remote Similarity NPC603859
0.5326 Remote Similarity NPC217083
0.5326 Remote Similarity NPC475805
0.5269 Remote Similarity NPC156432
0.5169 Remote Similarity NPC95842
0.5169 Remote Similarity NPC482612

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478515 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data